181
Participants
Start Date
May 17, 2018
Primary Completion Date
May 18, 2020
Study Completion Date
May 18, 2020
Accu-Chek® Solo micropump system
Medical device for subcutaneous delivery of insulin in a personalized way.
mylife™ OmniPod® Insulin Management System
A patch pump system delivering insulin.
Multiple Daily Injections (MDI) therapy
Injecting insulin as per participant's need.
Hietzing Hospital, Vienna
Salzburger Landeskliniken - Universitätsklinikum Salzburg (SALK), Salzburg
Diakonissen & Wehrle Privatklinik GmbH, Standort Andräviertel, Salzburg
Medizinische Universität Innsbruck, Innsbruck
VIVIT Institut am LKH Felkirch, Feldkirch
LKH Graz, Medizinische Universität Graz, Graz
Diabendo Praxiszentrum, Rostock
Gemeinschaftspraxis Drs Bieber Kraus Nolte Vortherms, Lage
Gemeinschaftspraxis im Altstadt-Carree, Fulda
InnoDiab Forschung GmbH, Essen
Diabeteszentrum am CKQ, Quakenbrück
Diabetes Klinik Bad Mergentheim GmbH, Bad Mergentheim
Regionalne Centrum Diabetologii - Uniwersyteckie Centrum Kliniczne, Gdansk
Jagiellonian University, Krakow
Central Clinical Hospital of the MSWiA in Warsaw, Warsaw
Bournemouth Diabetes and Endocrine Centre, Bournemouth
Wolfson Diabetes & Endocrine Clinic, Cambridge
Centre for Clinical Research and Innovation, Darlington
King's College London, Diabetes Research Group, London
Imperial College London, Diabetes, Endocrinology and Metabolism Division, London
Manchester Royal Infirmary, University Hospital, Manchester
Hoffmann-La Roche
INDUSTRY